Texas Diabetes Institute/UH
Texas Diabetes Institute/UH
San Antonio, Texas, United States5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants | Heart Failure With Preserved Ejection Fraction; Type 2 Diabetes Mellitus in Obese | Recruiting | Phase 4 | 2026-09-22 | NCT05838287 | |
| SGLT2i, Pioglitazone, and Ketone Production in T2D | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 1 | 2026-07-17 | NCT07053319 | |
| SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 1 | 2026-07-17 | NCT07053306 | |
| SGLT2i, Hepatic Glucose Production, and SNS | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Early phase 1 | 2026-07-17 | NCT07053293 | |
| SGLTi, Hepatic Glucose Production and Ketogenesis | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 1 | 2026-07-17 | NCT05960656 |